Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.

Anticancer research - 1 Jan 2000

Martínez-Arribas F, Núñez-Villar M J, Lucas A R, Sánchez J, Tejerina A, Schneider J

Abstract excerpt

BACKGROUND: The balance between the expression of the antiapoptotic gene Bcl-2 and the proapoptotic gene Bax is considered a good indicator of the apoptotic activity of tumor cells. Bcl-2 and Bax expression seem also to individually play a prognostic role in breast cancer. Our aim was to study the expression of both genes in fresh breast cancer samples, and to correlate the obtained results with other available...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to bcl-2-Associated X Protein
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Ploidies

Share to Proto-Oncogene Proteins c-bcl-2

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 12680147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.PMID 12680147Read ↗

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.Semantic proximity Read ↗

Regulators of apoptosis in human breast cancer.Semantic proximity Read ↗

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.Semantic proximity Read ↗

[Evaluation of expression and correlation between P53, BCL-2 and BAX proteins in ovarian neoplasms].Semantic proximity Read ↗

Expression of pro‐apoptotic Bax and anti‐apoptotic Bcl‐2 proteins in human retinoblastomaSemantic proximity Read ↗

REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIASemantic proximity Read ↗

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.Semantic proximity Read ↗

Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.Semantic proximity Read ↗

Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.Semantic proximity Read ↗

c-myc, p53 andbcl-2, apoptosis-related genes in infiltrating breast carcinomas: Evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsSemantic proximity Read ↗

Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

Expression of the <i>bcl</i>‐2 gene family in normal and malignant breast tissue: Low <i>bax</i>‐α expression in tumor cells correlates with resistance towards apoptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.